Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 12 Month Study to Assess Safety and Efficacy of Meridia (Sibutramine Hydrochloride Monohydrate) 10 and 15 mg in Obese Adolescents

NCT00261911 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00261911
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00261911 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 12 Month Study to Assess Safety and Efficacy of Meridia (Sibutramine Hydrochloride Monohydrate) 10 and 15 mg in Obese Adolescents
Lead sponsor
Abbott
Phase
Phase 3
Overall status
Completed
Start date
July 31, 2000
Completion date
February 28, 2002
Enrollment
498 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

obesity